It's time to eliminate the mismatch between pediatric training and practice
1Centre for Community Child Health, Royal Children's Hospital Melbourne, Murdoch Children's Research Institute, Melbourne, Australia. frank.oberklaid@rch.org.au.
Israel Journal of Health Policy Research
|December 3, 2021
Summary
Pediatric residency training needs a major overhaul to align with current child health needs and evidence-based practices. Current programs inadequately prepare pediatricians for community settings, particularly in child development.
Area of Science:
- Pediatrics
- Medical Education
- Community Child Health
Background:
- Pediatric residency training is crucial for preparing physicians for community practice.
- Despite significant shifts in pediatric morbidity over decades, training models remain largely unchanged.
- Existing training inadequately prepares pediatricians for contemporary clinical challenges.
Discussion:
- There is a notable discrepancy between current pediatric training content and evidence-based clinical practice.
- Specific deficiencies exist in training related to child development, as highlighted in recent literature.
- Pediatric training in Israel faces widespread criticism for its lack of focus on community child health and developmental-behavioral pediatrics.
Key Insights:
- Pediatric residency programs often fail to equip graduates with the necessary skills for modern community pediatric practice.
- Child development and behavioral pediatrics are underrepresented areas in current pediatric training curricula.
- A significant gap exists between the skills acquired during residency and the demands of evidence-based pediatric care.
Outlook:
- Calls for reform in pediatric training are increasing, emphasizing community child health and developmental-behavioral pediatrics.
- Initial steps towards revising training programs are being observed, but are considered insufficient.
- A fundamental and comprehensive reevaluation of pediatric residency training programs is urgently recommended to bridge the gap between training and practice.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
19
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Pharmacokinetics in Pediatric Patients: Drug Metabolism
27
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
18
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Drug Dosing: Infants and Children
33
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
33
Mismatch Repair
5.4K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution
20
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20


